Natural killer cells may be potentially powerful, but not fully understood, immune system cancer fighters. Until now, there has been little known about how to effectively stimulate a NK cell response in patients — but new research in animal models has identified a pathway that may provide an approach for scientists to harness NK cells as a form of a cancer immunotherapy.
As a chef in training who dreams of opening his own restaurant, Josh Gartland, 15, knows the importance of a good recipe. When it comes to the genetic disorder known as von Hippel-Lindau syndrome, which caused him to develop multiple tumors in his body, Josh also knows the value of a good treatment plan – and experts in the Endocrine-Oncology Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center provided one he and his family credit for saving his life.
Sign up to subscribe to any of our e-newsletters or digital content.
